About
Corvivo Cardiovascular, Inc. is a regenerative biotechnology company based in Gainesville, Florida. Corvivo is the world leader in cardiovascular regeneration, addressing the largest challenges in cardiovascular disease, including valvular heart disease and myocardial infarction. It is developing the CorTricuspid ECM® Valve for the surgical management of tricuspid valve disease and dysfunction in adult and pediatric patients. The company is also expanding its epicardial repair program with its FDA-cleared CorPatch® epicardial patch. CorPatch® is a second-generation extracellular matrix device engineered for epicardial placement for support and repair of weakened areas of the heart after myocardial infarction.
Technologies
Keywords
Company Information
-
Employees 13
-
Founded 2012
-
Annual Revenue $14000000
-
Total Funding $16360015
Location
Gainesville, Florida, United States